Your cart is empty.
Avacta Group in York, UK, has chosen Tecan’s Infinite M200 microplate reader to play a pivotal role in offering innovative analytical services to the biopharmaceutical sector, where high quality and reproducible data acquisition is crucial.
Russell Hodgetts, MD of Avacta’s Laboratory Services, explained: “The Infinite M200 allows us to provide quality, high throughput services to our clients, and is integral to the development of solubility screening assays, which are the starting point for our formulation development service. The multiple detection methods and environmental control available with the Tecan instrument make it extremely versatile.”
Avacta has recently developed MIDAS (multi immuno diagnostic assay system), a point-of-care platform designed to automate medical diagnostic tests usually performed manually in a laboratory. The Infinite plate reader has been central to this bioassay development, as Product Manager Dr Ed Quinn, explained: “The multimode detection capabilities of the Infinite reader allow us to carry out a wide range of assaying techniques – using absorbance, fluorescence and luminescence detection – on one instrument, and the built-in temperature control and shaking mean that the complete assay can be performed in situ. The easy-to-use icontrol™ software allows us to rapidly set up experiments, defining our own plate parameters to improve the resolution of our assays. Data is automatically exported to our laboratory information system, seamlessly integrating into our research and development program.”
To find out more on Tecan’s Infinite M200 reader, visit www.tecan.com/infinite200
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).
Tecan Trading Ltd